2 Patents
- US124157972025Heterocyclic Compound as CDK-HDAC Double-channel Inhibitor
Hangzhou Innogate Pharma Co., Ltd.
0 cites - US123589112025Heterocyclic Comipound as CDK-HDAC Dual Pathway Inhibitor
Hangzhou Innogate Pharma Co., Ltd.
0 cites
Hangzhou Innogate Pharma Co., Ltd.
Hangzhou Innogate Pharma Co., Ltd.